GlaxoSmithKline PLC (GSK)

GSK (NYSE:Drugs)
$52.51
neg -0.31
-0.59%
Today's Range: 52.28 - 52.75 | GSK Avg Daily Volume: 2,452,700
Last Update: 04/17/14 - 4:00 PM EDT
Volume: 2,219,393
YTD Performance: -1.65%
Open: $52.34
Previous Close: $52.82
52 Week Range: $48.30 - $56.73
Oustanding Shares: 2,427,386,516
Market Cap: 128,214,555,775
6-Month Chart
TheStreet Ratings Grade for GSK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 2
Moderate Buy 0 0 0 0
Hold 7 7 7 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.75 2.75 2.75 2.43
Latest Dividend: 0.75
Latest Dividend Yield: 4.51%
Dividend Ex-Date: 02/19/14
Price Earnings Ratio: 18.81
Price Earnings Comparisons:
GSK Sector Avg. S&P 500
18.81 14.50 29.01
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-2.94% 4.31% 27.67%
GROWTH 12 Mo 3 Yr CAGR
Revenue 2.30 0.00 0.00
Net Income 21.10 2.25 0.47
EPS 23.20 2.75 0.55
Earnings for GSK:
EBITDA 11.43B
Revenue 43.71B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.72 $0.81 $3.61 $3.93
Number of Analysts 3 2 8 7
High Estimate $0.80 $0.84 $3.77 $4.16
Low Estimate $0.68 $0.78 $3.37 $3.65
Prior Year $0.82 $0.80 $3.46 $3.61
Growth Rate (Year over Year) -11.79% 1.25% 4.37% 8.95%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

The Cloud Is the Prescription Real Money Pro($)

Medidata Solutions is focusing its cloud-computing offerings on the pharmaceutical industry.
The untold story about these stocks is how they have held up.
Bullish
Aug 14, 2013 | 8:00 AM EDT
GSK was upgraded to Neutral, JP Morgan said. Upcoming catalysts balance out earnings risk. 
The UK is the next geographic hotspot. Play it with this ETF.
Bullish
Jun 17, 2013 | 8:06 AM EDT
GSK earnings estimates were increased to reflect the multi-blockbuster potential of MAGE A3, said UBS. Price target goes to $54.81.
You can't get away from the need for good yield in an era of commodity inflation.
Let's look at five holdings that stayed in his portfolio for at least a year.

Columnist Conversations

There were nice reversal-type candles on the weekly charts of the major indices. The DOW and the S&P forme...
A number of stocks on my watch lists are attempting to form positive candles a key support levels. I noted th...
Lang:
While last week was a day to pull the plug and contemplate where the market was headed, I waited for some conf...
Shares of TSLA have formed multiple hammer candles at a key level of support defined by: the September head an...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.